mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-06 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-06 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |